Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd. (PHH) Stock Ownership
Latest 13F position summary is not yet available — breakdown and tables fill in after filings publish (typically ~45 days after quarter end).
SEC 13F · FMP · PHH · as of —
Ownership Breakdown
Institutional data for this period is not yet available. SEC Form 13F filings are typically published 45 days after quarter end.
No institutional data available for this period.
Insider Buying vs Selling
PHH insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Bogansky Michael R SVP & CFO | Oct 4, 2018 | D-Return | 13,074 | $11.00 | $143.8K | 0 | Form 4 ↗ |
STEIN KEVIN director | Oct 4, 2018 | D-Return | 5,467 | $11.00 | $60.1K | 0 | Form 4 ↗ |
PIZZI CHARLES P director | Oct 4, 2018 | D-Return | 28,053 | $11.00 | $308.6K | 0 | Form 4 ↗ |
Neuhauser James C director | Oct 4, 2018 | D-Return | 7,942 | $11.00 | $87.4K | 0 | Form 4 ↗ |
CROWL ROBERT B CEO | Oct 4, 2018 | D-Return | 88,238 | $11.00 | $970.6K | 0 | Form 4 ↗ |
Carlin Jane D director | Oct 4, 2018 | D-Return | 34,228 | $11.00 | $376.5K | 0 | Form 4 ↗ |
CROWL ROBERT B CEO | May 22, 2018 | Tax Withhold | 9,599 | $10.77 | $103.4K | 109.0K | Form 4 ↗ |
Bogansky Michael R SVP & CFO | May 22, 2018 | Tax Withhold | 4,226 | $10.77 | $45.5K | 23.3K | Form 4 ↗ |
STEIN KEVIN director | Apr 2, 2018 | Sale | 825 | $10.46 | $8.6K | 5.5K | Form 4 ↗ |
CROWL ROBERT B CEO | Feb 25, 2018 | Tax Withhold | 1,559 | $8.68 | $13.5K | 118.6K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Park Ha Biological Technology Co., Ltd. (PHH) is primarily owned by institutional investors, who hold approximately — of total shares outstanding. Company insiders own approximately —, while retail and public investors account for the remaining —.
A total of 0 institutional investors currently hold PHH stock, with a combined institutional value of approximately $0 as of the most recent 13F filing period.
Frequently asked questions
PHH ownershipPark Ha Biological Technology Co., Ltd. (PHH) is primarily owned by institutional investors, who hold approximately — of shares. The largest shareholder is — with a — stake. Company insiders hold —. Data sourced from SEC Form 13F as of —.